Magical solutions are not in vision, but novel approaches are needed totry to tackle the issue of antimicrobial resistance. A relative dry pipeline of antibiotic production has as early as 2010, caused the Infectious Diseases Society of America to express its concerns, the 10 × 20 initiative, and call for the production of 10 new antibacterial agents until 2020 [26].